News

Podcast

Pharmacy Focus: Oncology Edition – Key Insights and Interviews From the 2024 SABCS Meeting

Author(s):

Alexandra Gerlach, Associate Editor

Pharmacy Times attended the 2024 San Antonio Breast Cancer Symposium from December 10 to December 13.

This episode of Pharmacy Focus: Oncology Edition highlights key insights from the 2024 San Antonio Breast Cancer Symposium, covering new FDA-approved therapies, dose optimization strategies, and innovative prevention approaches in breast cancer care.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
American Captial Building.
Related Content
Model depicting chronic kidney disease (CKD) -- Image credit: NanSan | stock.adobe.com
September 3rd 2025

Regardless of Kidney Function, Abelacimab Consistently Reduced Bleeding Risk in Patients With AF

Gillian McGovern, Associate Editor
Pharmacy Focus Oncology Edition Podcast
September 3rd 2025

Protecting Community Oncology Practices in the Wake of the IRA

Alexandra Gerlach, Associate Editor
Models On screen, drawing representing an artery obstructed by a thrombus caused by a plaque of atheroma
September 3rd 2025

Individuals With Very High Cardiovascular Risk Struggle to Attain LDL-C Goals

Luke Halpern, Assistant Editor
From Guidelines to Action: Pharmacy’s Role in Hypertension Management
September 3rd 2025

From Guidelines to Action: Pharmacy’s Role in Hypertension Management

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
Patient self-administering subcutaneous injection | Image Credit: © - stock.adobe.commanusapon
September 3rd 2025

Subcutaneous Bortezomib Associated With Reduced Incidence of Peripheral Neuropathy in Multiple Myeloma

Alexandra Gerlach, Associate Editor
FDA waives clinical efficacy studies for certain biosimilars -- Image credit: Kamitana | stock.adobe.com
September 3rd 2025

FDA to Waive Clinical Efficacy Studies for Monoclonal Antibody Biosimilars

Gillian McGovern, Associate Editor
© 2025 MJH Life Sciences

All rights reserved.